Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
SLN
8 quarters
Position history for JPMorgan Chase & Co.'s holdings in Silence Therapeutics Plc
Yes. JPMorgan Chase holds 3,649 shares of SLN (Silence Therapeutics), worth $39,409, as of its Q3 2026 13F filing. It reduced the position by 214 shares (-5.5%) from Q2 2026. JPMorgan Chase has held SLN since Q4 2024, across 8 quarterly 13F filings.
Current Value
$39,409
Current Shares
3,649
Total Value Change
+$13,313
Total Shares Change
-144
Quarter-by-Quarter History
Other major holders of SLN: FMR LLC, Millennium Management LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc